Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TLR4 | O00206 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PPM1B | O75688 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8215658 | 1.00 | MAPT (0.45) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL10850819 | 1.00 | MAPT (0.45) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL8991772 | 0.95 | MAPT (0.49) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL8991774 | 0.95 | MAPT (0.49) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL3189910 | 0.93 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL10479620 | 0.93 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL10479615 | 0.93 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL3189915 | 0.93 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL10844426 | 0.90 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL10844424 | 0.90 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112961042-B | Synthesis method of trans-4- (trans-4' -alkyl cyclohexyl) cyclohexyl formaldehyde | 惠泽化学科技(濮阳)有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-112961042-A | Synthesis method of trans-4- (trans-4' -alkylcyclohexyl) cyclohexyl formaldehyde | 惠泽化学科技(濮阳)有限公司 | 2021-06-15 | — | — | CN | disclosed |
| EP-2607451-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2019-01-23 | — | — | EP | disclosed |
| US-8388861-B2 | Liquid crystal compound and liquid crystal mixture | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2013-03-05 | — | — | US | disclosed |
| US-8388861-B2 | Liquid crystal compound and liquid crystal mixture | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2013-03-05 | — | — | US | disclosed |
| US-20120132854-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL MIXTURE | JIANGSU HECHENG CHEMICAL MATERIALS CO., LTD. (CN) | 2012-05-31 | — | — | US | disclosed |
| US-20120132854-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL MIXTURE | JIANGSU HECHENG CHEMICAL MATERIALS CO., LTD. (CN) | 2012-05-31 | — | — | US | disclosed |
| US-4617140-A | Bicyclohexyl derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120132854-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL MIXTURE | CPNE4, LEO1, NCAPD3 | MAPT 2362/4885MEN1 616/4885KMT2A 4473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.